MDLN logo

MEDLINE INC-CL A

MDLNNASDAQ
πŸ† #437 by market capUS Equity
$34.92β–Ό $0.15 (βˆ’0.44%)
Live
πŸ””
Track MDLN
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.4%
7dβ–² 1.4%
14dβ–² 8.8%
30dβ–Ό 1.1%
ytdβ–Ό 16.8%
1yβ€”
🏦Market Cap
$29.52B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+11.5%
Healthy
πŸ“ŠGross Margin
25.0%
Moderate
πŸ’΅FCF Margin
6.8%
Moderate
βš–οΈP/S Ratio
1.0x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$34.77 – $35.32
52-Week Range
$31.49 – $50.88
Volume
$3.46B
Avg Volume
$4.11B
Shares Outstanding
845.6M
Next Earnings
Dec 14, 2026

Fundamentals Snapshot

Annual Revenue
$28.43B
Last Q Revenue
$7.68B
P/E Ratio
40.6
P/S Ratio
1.0x
EPS (TTM)
$0.81
Dividend Yield
0.00%
Dilution (1yr)
+3.2%

Why Investors Own MDLN

  • βœ“High-growth profile β€” revenue up +17.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 79% gross margin and 23% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

MDLN logo

MEDLINE INC-CL A

MDLN
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$28.4Bβ–² +11.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
26.4%β–² +7.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.2Bβ–Ό βˆ’0.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.3Bβ–Ό βˆ’7.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
812.0Mβ–² +3.2% YoY
StockOtter Β· stockotter.space

About MEDLINE INC-CL A

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
80/100

Analyst Price Target

β“˜
Average Target
$40.65
β–² +16.4% Upside
High Target$46.81
Low Target$37.36
Based on 15 analysts

Latest News & Updates

PRNewsWireΒ·11h ago

Medline Legal Alert: Medline (MDLN) Investors who Lost Money are Notified of the Ongoing Securities Fraud Investigation

BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Sept.

GlobeNewsWireΒ·1d ago

MEDLINE INC. INVESTIGATION: MDLN Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Medline Inc. (β€œMedline” or the β€œCompany”) (NASDAQ: MDLN). The investigation concerns whether the

Newsfile CorpΒ·1d ago

Kaplan Fox is Investigating Medline Inc. (MDLN) on Behalf of Shareholders for Possible Securities Law Violations

New York, New York--(Newsfile Corp. - September 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO REC

GlobeNewsWireΒ·1d ago

MDLN Investor Investigation: Medline Under Investigation for Securities Fraud on behalf of Investors with Losses – Contact BFA Law

BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Sept.

GlobeNewsWireΒ·4d ago

MDLN Stock Drop Alert: Medline Stock Plummets 13% after Product Quality Issues Revealed – BFA Law Notifies Investors of its Ongoing Securities Fraud Investigation

NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firmΒ  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock d

Newsfile CorpΒ·5d ago

Kaplan Fox Advises Investors of Medline Inc. (MDLN) to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO REC